EE689 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment (Monotherapy) for Adult Patients With Non-Small Cell Lung Cancer Following Resection and Platinum-Based Chemotherapy in Greece
Abstract
Authors
N. Nomikos P. Naoum E. Karampli N. Jovanoski M. Kakouros G. Sideri-Papagianni I. Kyriopoulos E. Pavi K. Athanasakis